![](https://avac.org/wp-content/uploads/2023/03/RTWG2017_Global_Investment_by_Tech_Category-1-1024x1004.jpg)
In 2016, funding for HIV prevention R&D decreased by 3 percent (US$35 million) from the previous year, falling to US$1.17 billion. Funding in 2016 signals the lowest annual investment in HIV prevention R&D in more than a decade.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!